XTANT MEDICAL HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $2.24 per share for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2019-08-08
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2019-03-31 was $2.24.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2014-03-31 was $0.00.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2012-03-31 was $2.36.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2013 was $0.63, a 64.80% decline from fiscal 2012.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2012 was $1.79, a 38.28% decline from fiscal 2011.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2011 was $2.90.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | $2.24 10-Q · filed 2019-08-08 | ||||
| 2019-03-31 | $2.24 10-Q · filed 2019-05-15 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | ||||
| 2015-06-30 | $4.00 10-Q · filed 2016-08-10 | ||||
| 2014-06-30 | $7.10 10-Q · filed 2014-08-14 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $0.63 10-K · filed 2014-03-27 | ||||
| 2013-09-30 | $0.63 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $7.00 10-Q · filed 2014-08-14 | $0.70 10-Q · filed 2013-08-13 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $1.79 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $2.00 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | $2.15 10-Q · filed 2013-08-13 | ||||
| 2012-03-31 | $2.36 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $2.90 10-K · filed 2013-03-27 | ||||
| 2011-09-30 | $2.92 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | $4.10 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |